Experimental studies have shown that low VEGF expression is associated with poor clinical outcomes and that patients with IPF and higher circulating VEGF levels have better lung function and a more benign clinical phenotype [42]. This evidence concerns the gene VEGFA and idiopathic pulmonary fibrosis.